Literature DB >> 26763103

High frequency of Candida fabianii among clinical isolates biochemically identified as Candida pelliculosa and Candida utilis.

L Svobodova1, D Bednarova2, F Ruzicka3, V Chrenkova4, R Dobias5, N Mallatova6, V Buchta7, I Kocmanova8, P Olisarova9, N Stromerova10, Y Thongsri11, P Hamal1.   

Abstract

Clinical yeast isolates belonging to Candida pelliculosa, Candida utilis and Candida fabianii are difficult to distinguish in a routine mycology laboratory using common biochemical tests. The aims of this study were to determine the prevalence of C. pelliculosa, C. utilis and C. fabianii in clinical samples and to compare their minimum inhibitory concentrations (MICs) to systemic antifungals. Two hundred and forty-eight clinical yeast isolates obtained from eight large hospitals in the Czech Republic were included in this study. Identification was performed biochemically using ID 32C kit and by MALDI-TOF MS. MICs were determined using colorimetric broth dilution Sensititre YeastOne panels. From a total number of 248 isolates, 175 were identified as C. pelliculosa and 73 as C. utilis using the biochemical kit. In contrast, MALDI-TOF MS identified 222 isolates as C. fabianii, 20 as C. pelliculosa and 6 as C. utilis. The highest mean MICs were found in C. fabianii and, regardless of the studied species, in isolates from blood cultures and central venous catheters. MALDI-TOF MS revealed C. fabianii to be most prevalent in clinical samples as compared with the other studied species. Higher MIC values in C. fabianii support the importance of correct identification of this species.
© 2016 Blackwell Verlag GmbH.

Entities:  

Keywords:  zzm321990Candida fabianiizzm321990; MALDI-TOF MS; antifungal susceptibility testing; biochemical identification

Mesh:

Substances:

Year:  2016        PMID: 26763103     DOI: 10.1111/myc.12454

Source DB:  PubMed          Journal:  Mycoses        ISSN: 0933-7407            Impact factor:   4.377


  7 in total

1.  Peritonitis in a neonate due to Cyberlindnera fabianii, an ascomycetic yeast.

Authors:  H Hof; V Amann; C Tauber; A Paulun
Journal:  Infection       Date:  2017-08-20       Impact factor: 3.553

Review 2.  Matrix-Assisted Laser Desorption Ionization Time-of-Flight for Fungal Identification.

Authors:  Anna F Lau
Journal:  Clin Lab Med       Date:  2021-04-24       Impact factor: 2.172

3.  Comparison of 21-Plex PCR and API 20C AUX, MALDI-TOF MS, and rDNA Sequencing for a Wide Range of Clinically Isolated Yeast Species: Improved Identification by Combining 21-Plex PCR and API 20C AUX as an Alternative Strategy for Developing Countries.

Authors:  Amir Arastehfar; Farnaz Daneshnia; Mohammad Kord; Maryam Roudbary; Hossein Zarrinfar; Wenjie Fang; Sayed Jamal Hashemi; Mohammad Javad Najafzadeh; Sadegh Khodavaisy; Weihua Pan; Wanqing Liao; Hamid Badali; Sassan Rezaie; Kamiar Zomorodian; Ferry Hagen; Teun Boekhout
Journal:  Front Cell Infect Microbiol       Date:  2019-02-15       Impact factor: 5.293

4.  Candida pelliculosa sepsis in a neonate: a case report.

Authors:  Zeyu Cai; Wei Wei; Zhongle Cheng
Journal:  J Int Med Res       Date:  2021-01       Impact factor: 1.671

5.  Multiple organ dysfunction syndrome and death secondary to Cyberlindnera fabianii.

Authors:  Mehul Desai; Bradley Nitta; Hussain Dhanani; Svetolik Djurkovic; Shalika Katugaha
Journal:  Med Mycol Case Rep       Date:  2019-07-05

Review 6.  Unequivocal identification of an underestimated opportunistic yeast species, Cyberlindnera fabianii, and its close relatives using a dual-function PCR and literature review of published cases.

Authors:  Amir Arastehfar; Wenjie Fang; Abdullah M S Al-Hatmi; Mohammad Hosein Afsarian; Farnaz Daneshnia; Mina Bakhtiari; Sara Khanjari Sadati; Hamid Badali; Sadegh Khodavaisy; Ferry Hagen; Wanqing Liao; Weihua Pan; Kamiar Zomorodian; Teun Boekhout
Journal:  Med Mycol       Date:  2019-10-01       Impact factor: 4.076

7.  Identification and Antifungal Susceptibility Profiles of Cyberlindnera fabianii in Korea.

Authors:  Ji-Hyun Park; Junsang Oh; Hyunkyu Sang; Bhushan Shrestha; Hyeyoung Lee; Jehyun Koo; Sung-Il Cho; Ji Seon Choi; Min-Ha Lee; Jayoung Kim; Gi-Ho Sung
Journal:  Mycobiology       Date:  2019-09-03       Impact factor: 1.858

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.